Revenio Group Corporation, Stock Exchange Release, March 1, 2017 at 9:00

Notice of the Annual General Meeting of Revenio Group Corporation

Notice is given to the shareholders of Revenio Group Corporation of the Annual General Meeting to be held on Wednesday, March 22, 2017, at 4.30 p.m. at Finlandia Hall, Congress wing Hall A, Mannerheimintie 13 e, FI-00100 Helsinki, Finland (entrances M1 and K1). The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 3.30 p.m.

After the annual general meeting is held, the shareholders will have the opportunity to meet the CEO&President and members of the management team of the Revenio Group Corporation at a coffee event.

A. Matters on the agenda of the general meeting

The following matters will be considered at the General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election of the persons to confirm the minutes and to supervise the counting of votes

4. Recording the legal convening of the meeting and quorum

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation of the annual accounts, the Report of the Board of Directors, and the auditor's report for the year 2016

- Review by the President and CEO

7. Adoption of the annual accounts

8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend

The Board of Directors proposes to the AGM that a per-share dividend of EUR 0.74 be paid for the financial year 2016. The dividend is paid to those shareholders who, on the dividend record date of March 24, 2017, are entered as shareholders on the Company's shareholder register as held by Euroclear Finland Ltd. The Board proposes that the dividend payment date be March 31, 2017.

9. Resolution on the discharge of the members of the Board of Directors and the President and CEO from liability

10. Resolution on the remuneration of the members of the Board of Directors and on the grounds for compensation of travel expenses

The Board of Directors proposes that the remuneration paid to the members of the Board of Directors to be elected at the AGM for the term until the close of the AGM in 2018 be as follows: EUR 48,000 for the Chair and EUR 24,000 for the members of the Board of Directors. The Board of Directors proposes that 40 percent of Board members' emoluments will be settled in the form of shares in the Company, while 60 percent will consist of a monetary payment.

Moreover, the Board of Directors proposes that the travel expenses of the regular members of the Board of Directors be compensated in accordance with Company's travel expense regulations.

11. Resolution on the number of members of the Board of Directors

The Board of Directors proposes that five regular members be elected to the Board of Directors.

12. Election of the members of the Board of Directors

Shareholders accounting for a total of 14.86 percent of all shares and voting rights in the Company have informed the Company that they will propose that Kyösti Kakkonen, Ari Kohonen, Pekka Rönkä, Ann-Christine Sundell and Pekka Tammela shall be re-elected as members of the Board of Directors.

13. Resolution on the remuneration of the auditor

The Board of Directors proposes that remuneration for the auditor shall be paid against the invoice approved by the Company.

14. Election of the auditor

The Board of Directors proposes that authorised public accountants Deloitte & Touche Oy, who have named Authorized Public Accountant Elina Reilander as the chief auditor, be elected as the auditor. The presentation of Elina Reilander is available at Revenio Group Corporation's website www.revenio.fi.

15. Authorizing the Board of Directors to decide to repurchase the Company's own shares

The Board of Directors proposes that the AGM authorize the Board to decide to repurchase a maximum of 797,940 of the Company's own shares in one or several tranches using the Company's non-restricted equity capital. 

The Company may buy back shares in order to develop its capital structure, finance and implement any corporate acquisitions or other transactions, implement share-based incentive plans, or otherwise transfer or cancel them.

The Company may buy back shares in public trading on marketplaces whose rules and regulations allow the Company to trade in its own shares. In such a case, the Company buys back shares through a directed purchase, that is, in a proportion other than its shareholders' holdings in Company shares, with the consideration for the shares based on their publicly quoted market price, in such a manner that the minimum price of the purchased shares equals the lowest market price quoted in public trading during the authorization period, and, similarly, their highest price equals the highest market price quoted in public trading during that period.

The Board proposes that the authorization be valid until April 30, 2018. This authorization shall supersede the buyback authorization granted at the AGM of March 15, 2016.

16. Authorization to the Board of Directors to decide on a share issue and on the granting of stock options and other special rights giving entitlement to shares

The Board of Directors proposes that the AGM authorize the Board to decide on a share issue of a maximum of 797.940 shares or to grant special rights (including stock options) entitling holders to shares as referred to in Chapter 10 Section 1 of the Companies Act, in one or several tranches.

This authorization is proposed to be used to finance and implement any prospective corporate acquisitions or other transactions, to implement the company's share-based incentive plans, or for other purposes determined by the Board. 

The authorization is also proposed to grant the Board the right to decide on all terms and conditions governing said share issue and the granting of special rights, including the subscribers or the grantees of said special rights and the payable consideration. The authorization also includes the right to waive shareholders' pre-emptive subscription rights and covers the issue of new shares and the transfer of any shares that may be held by the company.

The Board proposes that the authorization be valid until April 30, 2018. This authorization shall supersede the authorization to decide on a share issue and on the granting of special rights giving entitlement to shares granted in the AGM of March 15, 2016.

17. Reduction in share premium reserve

The Board of Directors proposes that the share premium reserve included in restricted equity in the parent company's balance sheet as per December 31, 2016 be reduced by transferring all funds, EUR 2,439,301.82 to the company's reserve for invested non-restricted equity.

Share premium reserve is included in restricted equity, which is subject to usage limitations. After the proposed reduction, the assets would be included in non-restricted equity, which would permit a more flexible capital structure and thereby more efficient use of the company's assets.

The reduction in the share premium reserve involves no compensation and does not affect the number of company shares, shareholders' rights, or the proportional ownership of shareholders. Entry into force of the proposed reduction requires a public announcement and registration by Finnish Patent and Registration Office. The Board of Directors will make decisions regarding all practicalities related to the reduction of the share premium reserve.

18. Closing of the meeting

B. Documents of the General Meeting

The abovementioned proposals for resolution on the AGM agenda and this notice are available on the website of Revenio Group Corporation at www.revenio.fi. Revenio Group Corporation's Annual Report, including the financial statements, Report of the Board of Directors and auditor's report, will be available on the website no later than March 1, 2017. Proposals for resolution and the abovementioned documents will also be available at the AGM, and copies of them as well as this notice will be sent to shareholders upon request. The Minutes of the AGM will be available on the abovementioned website from April 5, 2017 at the latest.

C. Instructions to meeting participants

1. Shareholders registered in the shareholder register

Shareholders who are registered in the Company's shareholder register maintained by Euroclear Finland Ltd on March 10, 2017, have the right to attend the AGM. Shareholders whose shares are registered in their personal book-entry accounts in Finland are registered in the shareholder register of the Company.

Shareholders who are registered in the Company's shareholder register and wish to participate in the AGM must register for the meeting no later than March 17, 2017 at 4:00 p.m., by which time registration notices need to have been received. Registration options for the General Meeting are:

a) through the Company's website at www.revenio.fi

b) via e-mail to elina.kari@revenio.fi or

c) by mail to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510 Vantaa, Finland.

Upon registration, shareholders should give their name, personal identity code or business ID, address, telephone number, name of assistant or proxy representative, if any, and the personal identity code of the proxy representative. Personal information given by shareholders to Revenio Group Corporation shall be used only in connection with the General Meeting and with the processing of related registrations. Shareholders, their representatives or proxy representatives must be able to prove their identity and/or proxy authorization at the meeting venue when requested.

2. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the AGM by virtue of such shares based on which the holder would, on March 10, 2017, be entitled to be registered in the shareholder register held by Euroclear Finland Ltd. Moreover, in order to participate in the AGM, holders of nominee-registered shares are required to be temporarily registered, based on such shares, in the shareholder register held by Euroclear Finland Ltd, no later than March 17, 2017, at 10:00 a.m. For nominee-registered shares, this constitutes due registration for the General Meeting.

Holders of nominee-registered shares are advised to request, without delay, all necessary instructions pertaining to registration in the temporary shareholder register, the issuing of proxy documents, and registration for the General Meeting from their asset managers. The asset manager's account operator must sign up holders of nominee-registered shares who wish to participate in the General Meeting for registration to the Company's temporary shareholder register no later than on the aforementioned date and time.

3. Proxy representation and powers of attorney

Shareholders may participate in the General Meeting and exercise their rights at the meeting by way of proxy representation. A shareholder's proxy representative shall present a dated power of attorney or shall otherwise in a reliable manner prove that he/she is authorized to represent the shareholder. If a shareholder participates in the General Meeting by way of several proxy representatives, representing the shareholder with shares in different securities accounts, the shares by which each proxy representative represents the shareholder must be identified upon registration.

Proxy documents, if any, should be delivered as originals to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510 Vantaa, Finland, before the last date for registration.

4. Other instructions and information

Pursuant to Chapter 5, Section 25 of the Finnish Companies Act, a shareholder who is present at the General Meeting has the right to request information on matters on the meeting's agenda.

On the date of this notice, March 1, 2017, the total number of shares in Revenio Group Corporation is 7,979,406, representing the same number of votes.

Vantaa, March 1, 2017

REVENIO GROUP CORPORATION
BOARD OF DIRECTORS

For further information, please contact:
CEO Timo Hildén
Telephone: +358 40 580 4774
timo.hilden@revenio.fi
www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki
Financial Supervisory Authority
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose worldwide success is based on intraocular pressure measurement technology that has a strong patent. Revenio Group consists of, in addition to the parent company, Icare Finland Oy which focuses on intraocular pressure measurement technology and its fully owned subsidiary Icare USA Inc., research and development company Revenio Research Oy and Oscare Medical Oy, in which Revenio holds a 53.5% interest. The common denominators of Revenio's business operations include screening, follow-up, and the global need to make cost savings through preventive health care.

Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The focus of Revenio's screening technology is on the early detection of glaucoma, osteoporosis, skin cancer, and asthma, and the monitoring of these during the treatment process.

In 2016, Revenio Group's net sales totaled MEUR 23.4, with its operating margin for continuing operations standing at 30.1% from continuous operations. Revenio Group Corporation is listed on Nasdaq Helsinki.